Belite Bio
BLTE
15 hedge funds and large institutions have $3.69M invested in Belite Bio in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
36% more funds holding
Funds holding: 11 → 15 (+4)
0.37% less ownership
Funds ownership: 0.63% → 0.26% (-0.37%)
57% less capital invested
Capital invested by funds: $8.52M → $3.69M (-$4.83M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$647K |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$411K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$313K |
| 4 |
JP Morgan Chase
New York
|
+$304K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$261K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$6.76M |
| 2 |
HF
HRT Financial
New York
|
-$247K |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$122K |
| 4 |
Morgan Stanley
New York
|
-$18.5K |
BLTE Hedge Fund Activity: Q3 2024 in Review
15 of the 6,979 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q3 2024, worth a combined $3.69M — down 57% from $8.52M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BLTE positions and 2 closed out — a net gain of 4 holders — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Bank of America, adding an estimated $647K. The largest seller was Armistice Capital, exiting entirely with an estimated $6.76M sold.
- 15 institutional investors held Belite Bio (BLTE) as of Q3 2024, up from 11 in Q2 2024.
- Funds reported $3.69M of Belite Bio stock for Q3 2024, down 57% quarter-over-quarter.
- 6 funds opened new Belite Bio positions in Q3 2024 and 2 closed out, a net change of +4 holders.
- The largest Belite Bio buyer in Q3 2024 was Bank of America, an estimated $647K added.
- The largest Belite Bio seller in Q3 2024 was Armistice Capital, an estimated $6.76M sold.
Based on aggregated 13F filings for Q3 2024.